How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? - Implications for therapeutic use

Author: Scheding S.   Franke H.   Diehl   Wichmann H.-E.   Brugger W.   Kanz L.   Schmitz S.  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.27, Iss.5, 1999-05, pp. : 956-965

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content